Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04449666

Hippocampal Volume and Memory Functions in Aneurysmal Subarachnoid Hemorrhage

Neuropsychological and functional long-term consequences of subarachnoid hemorrhages (SAH) represent a great challenge, since sometimes considerable cognitive deficits occur without evidence of substantial brain damage. In this study, we want to examine if the frequently observed memory deficits are associated with hippocampal atrophy.

Recruiting

Interested in participating?

Request Info

Key information

About this study

Long-term or even permanent neuropsychological impairments are frequently observed after aneurysmal subarachnoid hemorrhages (aSAH). Among the most common impairments after aSAH are memory deficits. Volumetric MRI studies suggest an association of memory dysfunctions with temporal atrophy, especially of the hippocampus. In a previous study, 77 patients with good or moderate clinical outcome after aSAH were examined one year after discharge (Bendel et al., 2006). Temporomesial atrophy was detected without direct brain damage, e.g. by secondary ischemia. Due to the effects of complex cognitive impairments on the quality of life and participation in social and professional life, this relationship will be examined in more detail in the planned study. Specifically, we will investigate to what extent the frequently observed discrepancy between severe memory impairment and normal structural imaging results (no focal lesions in temporomesial areas) is due to hippocampal atrophy. In contrast to Bender and colleagues, this question will be investigated in the acute phase of the disease, immediately after admission to inpatient neurological rehabilitation.

Over a period of 24 months, 29 neurological rehabilitation patients with aSAH (Hunt & Hess grade I and II) are going to be included. Within the first week (day 1 to 7) after study enrollment, a native MRI examination (without contrast agent) is performed, in which a high-resolution 3D-MPRAGE sequence (T1 weighting) is measured in the sagittal plane. After checking the data quality of the 3D-MPRAGE sequence, especially with regard to its suitability for hippocampal volume determination, a comprehensive neuropsychological examination is performed, in which specific memory and attentional functions are tested.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • neurological rehabilitation patients in phase B - D
  • at minimum eight weeks after disease onset
  • aneurysmal subarachnoid hemorrhage (Hunt & Hess grade I or II)
  • written consent from the patient's legal representative
  • exclusion of pregnancy

Exclusion criteria

  • insufficient cardiorespiratory stability
  • previous brain damage
  • mental disorders (dementia, depression)
  • colonization with multi-resistant pathogens
  • MRI contraindications
  • claustrophobia
  • weight > 120 kg

Treatment and study plan

Neuropsychological assessment and structural MRI

Diagnostic Test

Complex neuropsychological assessment testing attentional and memory functions. Additionally, a structural MRI is measured.

Primary outcomes

  1. Changed hippocampal volume in aSAB

    Time frame: 2 weeks

    Hypothesis: patients have smaller hippocampal volume than healthy control subjects. For the hippocampal volume a structural MRI scan (3D-MPRAGE) is obtained

Secondary outcomes

  1. Changed memory function in aSAB

    Time frame: 2 weeks

    Hypothesis: patients have lower scores in the Visual and Verbal memory test (VVM) than healthy control subjects.

  2. Influence of the type of therapy on the hippocampal volume

    Time frame: 2 weeks

    Hypothesis: hippocampal volumes differ between aSAH patients with surgical or endovascular treatment.

  3. Influence of the lesion site on the hippocampal volume

    Time frame: 2 weeks

    Hypothesis: there are no differences between ispi- and contralateral hippocampal volumes

  4. Interrater reliability

    Time frame: 2 weeks

    Hypothesis: It is expected that there will be no difference in the ratings of hippocampal volume between two independent raters.

  5. Changed intracranial volume in aSAB

    Time frame: 2 weeks

    Hypothesis: patients have smaller intracranial volume than healthy control subjects.

Study contacts

Contact information is provided by the study sponsor or research team.

Melanie Boltzmann, PhD

CONTACT

[email protected]

0049 5152 781 256

Simone B Schmidt, PhD

CONTACT

[email protected]

0049 5152 781 215

Sponsors and collaborators

Lead sponsor

BDH-Klinik Hessisch Oldendorf

Other

Registry information

Official study title

Investigation of the Relationship Between Hippocampal Volume and Memory Functions in in Patients With Aneurysmal Subarachnoid Hemorrhage (aSAH)

Important dates

Study start
2020
Primary completion
2026
Study completion
2026
First posted
Jun 29, 2020
Registry last updated
Sep 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.